Amorolfine

This classification denotes an enzyme inhibitor and antifungal agent with the molecular formula C21H35NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AB0BHP2FH0, chemically known as morpholine, 4-(3-(4-(1,1-dimethylpropyl)phenyl)-2-methylpropyl)-2,6-dimethyl-, cis-, (+-)- but generally known as amorolfine, which bears US NIH Compound Identifier 54260. Amorolfine most often comes in base and hydrochloride forms. European Medicines Agency schedules Amorolfine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05476MIG. The term AMOROLFINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). World Health Organization schedules amorolfine in its Anatomical Therapeutic Chemical (ATC) Classification. AMOROLFINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amorolfine under HS 29349990 and SITC 51579. As of Q4 2014, AMOROLFINE remains the US FDA Preferred Term for this commodity. Amorolfine bears US NLM identifiers UMLS ID C0051736 and NCI Concept Code C81332. SMILES: O1C(CN(CC(CC2CCC(C(CC)(C)C)CC2)C)CC1C)C.